TAMBURELLO, Mariangela
 Distribuzione geografica
Continente #
NA - Nord America 1.613
AS - Asia 898
EU - Europa 559
SA - Sud America 115
Continente sconosciuto - Info sul continente non disponibili 42
AF - Africa 16
OC - Oceania 7
Totale 3.250
Nazione #
US - Stati Uniti d'America 1.579
SG - Singapore 292
IT - Italia 249
CN - Cina 236
BR - Brasile 88
HK - Hong Kong 70
FI - Finlandia 62
DE - Germania 59
BD - Bangladesh 56
VN - Vietnam 52
JP - Giappone 42
IN - India 34
FR - Francia 30
GB - Regno Unito 30
RU - Federazione Russa 20
CA - Canada 19
TR - Turchia 19
AE - Emirati Arabi Uniti 16
ID - Indonesia 16
NL - Olanda 16
SE - Svezia 16
PL - Polonia 15
KR - Corea 12
PK - Pakistan 11
TW - Taiwan 10
CH - Svizzera 9
ES - Italia 9
AR - Argentina 8
IE - Irlanda 8
BE - Belgio 7
EC - Ecuador 6
MX - Messico 6
PT - Portogallo 6
EG - Egitto 5
IQ - Iraq 5
ZA - Sudafrica 5
AU - Australia 4
DZ - Algeria 4
LT - Lituania 4
MY - Malesia 4
CL - Cile 3
CO - Colombia 3
CR - Costa Rica 3
CZ - Repubblica Ceca 3
NZ - Nuova Zelanda 3
RO - Romania 3
VE - Venezuela 3
AL - Albania 2
AM - Armenia 2
EE - Estonia 2
GR - Grecia 2
GT - Guatemala 2
IR - Iran 2
JO - Giordania 2
LB - Libano 2
NP - Nepal 2
OM - Oman 2
PE - Perù 2
RS - Serbia 2
SA - Arabia Saudita 2
TH - Thailandia 2
UA - Ucraina 2
AT - Austria 1
AZ - Azerbaigian 1
BB - Barbados 1
BH - Bahrain 1
BS - Bahamas 1
HN - Honduras 1
HU - Ungheria 1
JM - Giamaica 1
KZ - Kazakistan 1
MA - Marocco 1
MD - Moldavia 1
PH - Filippine 1
PS - Palestinian Territory 1
PY - Paraguay 1
QA - Qatar 1
TN - Tunisia 1
UY - Uruguay 1
UZ - Uzbekistan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 3.209
Città #
Chicago 170
Singapore 167
San Jose 117
Ashburn 115
Los Angeles 98
Salt Lake City 78
Dallas 71
Hong Kong 64
New York 56
Council Bluffs 49
Brescia 42
Beijing 40
Tampa 38
Elk Grove Village 34
Helsinki 33
The Dalles 30
Milan 28
Buffalo 27
Columbus 26
Tokyo 25
Sterling 22
Lauterbourg 21
Secaucus 20
Chandler 19
Lancaster 19
Des Moines 18
Shanghai 18
Ho Chi Minh City 17
Istanbul 17
Munich 16
Turku 16
West Jordan 16
Rome 14
Santa Clara 14
Dubai 13
Hopkinton 13
Wilmington 11
Amsterdam 10
Bergamo 10
Dalmine 10
Boardman 9
Hanoi 9
Moscow 9
Charlotte 8
Houston 8
Philadelphia 8
Stockholm 8
São Paulo 8
Bologna 7
Boston 7
Brooklyn 7
Brussels 7
Denver 7
Dulles 7
Düsseldorf 7
Hakozaki 7
Jakarta 7
Kansas City 7
Lappeenranta 7
Miami 7
Montreal 7
Nuremberg 7
Orem 7
Atlanta 6
Calcinate 6
Las Vegas 6
Memphis 6
Mumbai 6
Naples 6
Princeton 6
Pune 6
Ruda Śląska 6
San Francisco 6
Seattle 6
Zurich 6
Ann Arbor 5
Augusta 5
Chennai 5
Detroit 5
Dublin 5
Fairfield 5
Hwaseong-si 5
Phoenix 5
Redondo Beach 5
Rio de Janeiro 5
Romola 5
Semarang 5
Vancouver 5
Würzburg 5
Zhubei 5
Cagliari 4
Casalmaggiore 4
Da Nang 4
Frankfurt am Main 4
Haiphong 4
Islamabad 4
Kuala Lumpur 4
London 4
Palermo 4
Parma 4
Totale 1.981
Nome #
Cytotoxic Effect of Progesterone, Tamoxifen and Their Combination in Experimental Cell Models of Human Adrenocortical Cancer 794
Carcinoma of the human adrenal cortex: identification and in vitro and in vivo study of molecular alterations as potential therapeutic targets 514
Ribociclib Cytotoxicity Alone Or Combined With Progesterone And/Or Mitotane In In Vitro Adrenocortical Carcinoma Cells 148
Advances in adrenocortical carcinoma pharmacotherapy: what is the current state of the art? 128
Preclinical Evidence of Progesterone as a New Pharmacological Strategy in Human Adrenocortical Carcinoma Cell Lines 128
Estrogen-Like Effect of Mitotane Explained by Its Agonist Activity on Estrogen Receptor-α 122
The CDK Inhibitor Dinaciclib Improves Cisplatin Response in Nonseminomatous Testicular Cancer: A Preclinical Study 117
Outcome of brain metastases from adrenocortical carcinoma: a pooled analysis 117
Trabectedin impairs invasiveness and metastasis in adrenocortical carcinoma preclinical models 115
Feasibility and Activity of Megestrol Acetate in Addition to Etoposide, Doxorubicin, Cisplatin, and Mitotane as First-Line Therapy in Patients with Metastatic/Unresectable Adrenocortical Carcinoma with Low Performance Status 115
FSCN1 as a new druggable target in adrenocortical carcinoma 114
An update on adrenocortical cell lines of human origin 107
A Database Tool Integrating Genomic and Pharmacologic Data from Adrenocortical Carcinoma (ACC) Cell Lines, PDX, and Patient Samples 88
Dlk1 is a novel adrenocortical stem/progenitor cell marker that predicts malignancy in adrenocortical carcinoma 87
RETROSPECTIVE ANALYSIS OF THE PATIENT-REPORTED ADVERSE DRUG REACTIONS IN AN ITALIAN ALLERGY UNIT: ALLERG-RAF STUDY 82
Cancer cell xenografts in zebrafish embryos as an experimental tool in drug screening for adrenocortical carcinoma 82
FGF/FGFR signaling in adrenocortical development and tumorigenesis: novel potential therapeutic targets in adrenocortical carcinoma 78
Chemo-immunotherapy with cisplatin and nivolumab as second-line approach in metastatic adrenocortical carcinoma 69
FGF/FGFR inhibitors downmodulates c-Myc oncoprotein and hampers the growth of adrenocortical carcinoma 69
Prognostic role of pretreatment [18F]FDG PET/CT in patients affected by adrenocortical carcinoma and treated with chemotherapy 42
Emerging role of IGF1R and IR expression and localisation in adrenocortical carcinomas 28
Pharmacological WEE1 inhibition as a strategy to overcome cisplatin resistance in non-seminoma testicular cancer: insights from preclinical models 28
Preclinical evaluation of progesterone combined with EDP-M scheme in 2D and 3D models of adrenocortical carcinoma 24
Primary Adrenal Malignancies 16
PPARG dysregulation as a potential molecular target in adrenal Cushing's syndrome 15
Erythropoiesis in Cushing syndrome: sex-related and subtype-specific differences. Results from a monocentric study 13
Updating ACC preclinical models: characterization of two new patient-derived cell lines 10
Totale 3.250
Categoria #
all - tutte 12.356
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.356


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202246 0 0 2 3 3 3 8 0 2 11 5 9
2022/2023113 6 2 5 3 8 9 4 18 17 10 17 14
2023/2024335 18 13 18 30 32 41 25 52 34 33 13 26
2024/20251.212 30 26 16 106 44 28 38 32 102 44 242 504
2025/20261.363 90 130 102 119 124 108 192 75 97 143 102 81
2026/2027164 67 55 42 0 0 0 0 0 0 0 0 0
Totale 3.250